Ascendis Pharma
ASND
$135.90
Share price
-0.75%
Change (1 day)
77.79%
Change (1 year)
Categories
P/S ratio for Ascendis Pharma (ASND)
P/S ratio as of April 2024 (TTM): 26.4
According to Ascendis Pharma 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 26.4107. At the end of 2023 the company had a P/S ratio of 24.5.
P/S ratio history for Ascendis Pharma from 2015 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 24.5 | -81.17% |
| 2022 | 130 | -84.84% |
| 2021 | 857 | -23.38% |
| 2020 | > 1000 | 151.14% |
| 2019 | 445 | 104.28% |
| 2018 | 218 | -73.75% |
| 2017 | 831 | 545.83% |
| 2016 | 129 | 150.82% |
| 2015 | 51.3 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 Akebia Therapeutics AKBA | 1.44 | -94.55% | 🇺🇸 USA |
 Affimed
AFMD | 8.54 | -67.66% | 🇩🇪 Germany |
 Advaxis ADXS | 171 | 548.61% | 🇺🇸 USA |